A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

Q1 2026 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...

According to reporting from Reuters, reviewers at the agency pointed to an inability to differentiate from placebo to justify rejecting the drug, but an FDA office director approved the drug anyway.

AstraZeneca Canada (AstraZeneca) and the Leukemia & Lymphoma Society of Canada (LLSC) are proud to announce the winners of the co-funded 2025 Operating Grants in Blood Cancer, a Canadian-based ...

Precision Biologics, Inc. announces in vitro?and?in vivo?efficacy of its novel tumor-specific ADC (PB-vcMMAE-5) against human carcinomas expressing truncated core 2 O-glycans. Recent data for several ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

The gene p53 acts as a tumor suppressor and is often called the guardian of the genome. This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to ...

Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, spoke with Healio about “clear-cut indicators” to differentiate between different types of autoimmune biliary diseases. He ...

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September ...

The treatment landscape for high-risk myelodysplastic syndromes (HR MDS) is evolving, moving from supportive care toward a ...